Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.24 AUD | +2.97% | +2.21% | +51.19% |
Business Summary
Number of employees: 234
Sales per Business
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Commercial
98.9
%
| 156 | 97.7 % | 497 | 98.9 % | +217.87% |
Product Development
1.1
%
| 4 | 2.3 % | 5 | 1.1 % | +47.46% |
Sales per region
AUD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
97.4
%
| 150 | 93.7 % | 490 | 97.4 % | +226.42% |
China
1.1
%
| 3 | 2.1 % | 5 | 1.1 % | +57.80% |
Other Countries
0.9
%
| 2 | 1.6 % | 5 | 0.9 % | +87.06% |
United Kingdom
0.3
%
| 2 | 1.3 % | 1 | 0.3 % | -36.14% |
Australia
0.2
%
| 0 | 0.1 % | 1 | 0.2 % | +682.55% |
Belgium
0.1
%
| 1 | 0.4 % | 0 | 0.1 % | -18.79% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Andreas Kluge
FOU | Founder | - | 15-10-31 |
Founder | - | 15-10-31 | |
Darren Smith
DFI | Director of Finance/CFO | 58 | 22-01-31 |
Craig Ulrick
CTO | Chief Tech/Sci/R&D Officer | - | - |
Tracey Brown
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-01-31 |
Chief Tech/Sci/R&D Officer | - | - | |
Melanie Farris
CMP | Compliance Officer | - | - |
David Cade
CTO | Chief Tech/Sci/R&D Officer | - | 19-10-06 |
Kyahn Williamson
IRC | Investor Relations Contact | - | 21-07-11 |
Meredith Crowe
HRO | Human Resources Officer | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Harry McCann
CHM | Chairman | 83 | 17-09-16 |
Founder | - | 15-10-31 | |
Mark Nelson
BRD | Director/Board Member | - | 17-09-16 |
Tiffany Olson
BRD | Director/Board Member | 64 | 22-03-30 |
Jann Skinner
BRD | Director/Board Member | 66 | 18-06-18 |
Andreas Kluge
FOU | Founder | - | 15-10-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 323,727,000 | 247,357,796 ( 76.41 %) | 0 | 76.41 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
3,298,073 | 1.02% | 27,734,947 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+51.19% | 3.33B | |
+25.69% | 47.86B | |
+46.90% | 41.42B | |
-3.46% | 40.66B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |
- Stock Market
- Equities
- TLX Stock
- Company Telix Pharmaceuticals Limited